Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial Meeting Abstract


Authors: Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; Ginsberg, M.; Rudin, C.; Kris, M.; Weitsman, G.; Barber, P.; Ng, T.; Ulaner, G.; Arcila, M.; Scaltriti, M.
Abstract Title: Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
Meeting Title: IASLC 19th World Conference on Lung Cancer
Keywords: antibody drug conjugate; her2 mutant lung cancers; her2 targeted imaging
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 10 Suppl.
Meeting Dates: 2018 Sep 23-26
Meeting Location: Toronto, Canada
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-10-01
Start Page: S599
Language: English
ACCESSION: WOS:000454014502055
DOI: 10.1016/j.jtho.2018.08.900
PROVIDER: wos
Notes: Meeting Abstract: P1.13-43 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Gary Ulaner
    121 Ulaner
  2. Michelle S Ginsberg
    179 Ginsberg
  3. Ronglai Shen
    147 Shen
  4. Maria Eugenia Arcila
    476 Arcila
  5. Mark Kris
    729 Kris
  6. Maurizio Scaltriti
    132 Scaltriti
  7. Charles Rudin
    249 Rudin
  8. Elizabeth   Panora
    6 Panora
  9. Bob Tingkan Li
    115 Li
  10. Michael David Offin
    57 Offin
  11. Zachary T Olah
    7 Olah
  12. Mackenzie Myers
    14 Myers